TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
IMRX

Immuneering Corp

Healthcare · Biotechnology

4.30$ -0.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow IMRX
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +338.7% +100.6% +74.3% +27.0% +9.4% -8.1%
– +82.2% +65.9% +125.5% +40.9% +13.5% -2.9%
– -61.3% +37.6% +172.2% – – –
– +186.6% -28.1% +90.7% -156.8% – –
– +160.2% +13.8% +1,121.5% -53.8% -75.2% +67.6%
– +160.2% +141,463.2% – -82.6% +262.3% -435.7%
– – – -100.0% – – –
– – – – – – –
– +121.2% +279.8% -100.0% +149,558.4% -81.4% +4,172.3%
– +83.4% +62.2% -106.0% – – –
– – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?